SCHEMBL7663185

SCHEMBL7663185

Cc1cc(S)cc(=O)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL981128 0.74
SCHEMBL1803845 0.70
4-Hydroxy-6-Methylpyran-2-One SCHEMBL320025 0.70
SCHEMBL12464950 0.70
SCHEMBL1804389 0.70
SCHEMBL4439220 0.70
SCHEMBL1263805 0.67 CA1 (0.54)
4-Hydroxy-6-Methylpyran-2-One SCHEMBL22656780 0.65 CYP3A4 (0.87)
SCHEMBL26387044 0.65 CA9 (0.52)
SCHEMBL6472513 0.65 KMT2A (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6384045-B1 TREATMENT OF ALZHEIMER'S DISEASE AND ANTICANCER AGENTS KANSAS STATE UNIVERSITY RESEARCH FOUNDATION 2002-05-07 US disclosed
EP-0418020-A2 Cephalosporinderivatives, process for their preparation and pharmaceutical compositions BEECHAM GROUP PLC (GB) 1991-03-20 EP disclosed